{"id":"W4323347380","doi":"10.1093/eurheartj/ehad144","title":"Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial","year":2023,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"National Institute for Health and Care Research; Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Hazard ratio; Placebo; PCSK9; Internal medicine; Mace; Statin; Acute coronary syndrome; Atorvastatin; Confidence interval; Cholesterol; Myocardial infarction; Lipoprotein; Percutaneous coronary intervention; LDL receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002020517,0.000934678,0.00189124,0.0002307796,0.0004545262,0.0009057917,0.0004670087,0.0008366765,0.003312627],"category_scores_gemma":[0.002273884,0.000371409,0.001635882,0.0002596423,0.0008822023,0.0008918691,0.001228078,0.001681391,0.0002345738],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004465424,"about_ca_system_score_gemma":0.0009521542,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002077223,"about_ca_topic_score_gemma":0.003664946,"domain_scores_codex":[0.9990191,0.0005389536,0.00007528818,0.0001633628,0.00009425429,0.0001090171],"domain_scores_gemma":[0.9988649,0.0002044142,0.0003342571,0.0001430505,0.00007083268,0.0003825517],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.947589,0.00397355,0.02589587,0.0007340931,0.003317369,0.00007759889,0.0001476404,0.0003234411,0.002096785,0.000331438,0.001649733,0.01386349],"study_design_scores_gemma":[0.8099847,0.05476479,0.1208663,0.0002141958,0.006198063,0.0003028541,0.0002232889,0.002008711,0.001301783,0.0008349136,0.003219515,0.00008095752],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949043,0.002236937,0.000227169,0.00043338,0.00009409498,0.0003504551,0.0008695349,0.00001913751,0.0008650693],"genre_scores_gemma":[0.9952449,0.001008897,0.0005087696,0.0005027584,0.0001707236,0.0004511079,0.001137365,0.000005860366,0.0009695562],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003312627,"threshold_uncertainty_score":0.01108181,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02471044105177115,"score_gpt":0.2585059212143827,"score_spread":0.2337954801626115,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}